Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZIPS-2: Zinc for Infection Prevention in Sickle Cell Anemia
NCT06561061Phase 3Completed
- Sponsor
- Indiana University
- Start
- Feb 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in sickle cell anemia (SCA) comparing Zinc with Placebo (2 arms). Primary endpoint: Incidence of all-cause infections at 6 months. Started Feb 2025; status: completed.
02
Drugs
zinc
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT06561061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06561061.